The site of the Media Sphera Publishers contains materials intended solely for healthcare professionals.
By closing this message, you confirm that you are a certified medical professional or a student of a medical educational institution.

Login
EN
+7 (495) 482-4118
+7 (495) 482-4329
+8 800 250-18-12
  • (toll-free number for subscriptions)
    Mon-Fri from 10 a.m. to 6 p.m.

  • © 1998-2026
+7 (495) 482-43-29
EN
All journals
Journal
Year
Year
Search result: 0

Timerbulatov Sh.V.

Department of Surgery with the courses of endoscopy and novel technologies, Institute of continuing professional education, Bashkir State Medical University, Ufa, Russia

Valiev R.Z.

Bashkir State Medical University of Healthcare Ministry of the Russian Federation, Ufa, Russia, Ufa State Aviation Technical University of Ministry of Education and Science of the Russian Federation, Ufa, Russia

Timerbulatov M.V.

Kafedra fakul'tetskoĭ khirurgii s kursom koloproktologii Bashkirskogo gosudarstvennogo meditsinskogo universiteta;
otdelenie koloproktologii MU Gorodskaia klinicheskaia bol'nitsa #21, Ufa

Nanobiomedical technologies in surgery

Authors:

Timerbulatov Sh.V., Valiev R.Z., Timerbulatov M.V.

More about the authors

Journal: Pirogov Russian Journal of Surgery. 2018;(1): 90‑98

DOI: 10.17116/hirurgia2018190-98

Read: 2632 times

Download PDF (RU)
Contact the author
Table of contents

NANOBIOMEDICAL TECHNOLOGIES IN SURGERY
NANOBIOMEDICAL TECHNOLOGIES IN SURGERY

To cite this article:

Timerbulatov ShV, Valiev RZ, Timerbulatov MV. Nanobiomedical technologies in surgery. Pirogov Russian Journal of Surgery. 2018;(1):90‑98. (In Russ.)
https://doi.org/10.17116/hirurgia2018190-98

Подписка 2026 Хирургия. Журнал им. Н.И. Пирогова (Pirogov Russian Journal of Surgery)
МСФ на ЯМ
Использование инфографики авторами научных работ
Close metadata
Recommended articles:
Postoperative peri­tonitis: epidemiology, diagnosis, surgical treatment and prognosis. Piro­gov Russian Journal of Surgery. 2025;(6):104-111
Combined treatment of patients with acute muscular tonic syndrome with dorsopathy. S.S. Korsakov Journal of Neurology and Psychiatry. 2025;(3):70-77
Characteristics, treatment features and in-hospital mortality of patients with myocardial infa­rction over 75 years old in Russia acco­rding to the REGION-IM regi­stry. Russian Cardiology Bulletin. 2025;(1):22-38
Pharmacological treatment and prevention of ischemia-reperfusion syndrome in percutaneous coro­nary inte­rvention. Russian Journal of Cardiology and Cardiovascular Surgery. 2025;(2):191-200
Influence of griseofulvin on inte­stinal microbiota in the treatment of microsporia in rural children. Russian Journal of Clinical Dermatology and Vene­reology. 2025;(2):185-190
Stress and sleep: Neurobiological aspe­cts and modern options of inso­mnia therapy. S.S. Korsakov Journal of Neurology and Psychiatry. 2025;(5-2):14-21
Cognitive impairment in patients with multiple scle­rosis. S.S. Korsakov Journal of Neurology and Psychiatry. 2025;(4-2):67-73
Early diagnosis and effe­ctive therapy of diabetic poly­neuropathy. S.S. Korsakov Journal of Neurology and Psychiatry. 2025;(5):62-68
Portopulmonary hype­rtension. Journal of Respiratory Medi­cine. 2025;(2):39-44
Diagnosis and treatment of ovarian cancer in pregnancy. Russian Bulletin of Obstetrician-Gynecologist. 2025;(3):27-33
Abstract:

Keywords:

nanobiomedical technologies
surgical diseases

Authors:

Timerbulatov Sh.V.

Department of Surgery with the courses of endoscopy and novel technologies, Institute of continuing professional education, Bashkir State Medical University, Ufa, Russia

Valiev R.Z.

Bashkir State Medical University of Healthcare Ministry of the Russian Federation, Ufa, Russia, Ufa State Aviation Technical University of Ministry of Education and Science of the Russian Federation, Ufa, Russia

Timerbulatov M.V.

Kafedra fakul'tetskoĭ khirurgii s kursom koloproktologii Bashkirskogo gosudarstvennogo meditsinskogo universiteta;
otdelenie koloproktologii MU Gorodskaia klinicheskaia bol'nitsa #21, Ufa

Close metadata

References:

  1. Nordanstig J, Gerdes H, Kocys E. Spontaneous isolated dissection of the celiac trunk with rupture of the proximal splenic artery: a case report. Eur J Vasc Endovasc. 2009;37:194-197. https://doi.org/10.1016/j.ejvs.2008.10.009
  2. Khademhosseini A, Langer R. Nanobiotechnology: drug delivery and tissue engineering. Chem Eng Prog. 2006;102:38-42.
  3. Petros RA, DeSimone JM. Strategies in the design of nanoparticles for therapeutic applications. Nat Rev Drug Discov. 2010;9:615-627. https://doi.org/10.1038/nrd2591
  4. Barenholz Y. Doxil: the first FDA-approved nano-drug: lessons learned. J Control Release. 2012;160:117-134. https://doi.org/10.1016/j.jconrel.2012.03.020
  5. Davis ME, Chen ZG, Shin DM. Nanoparticle therapeutics: an emerging treatment modality for cancer. Nat Rev Drug Discov. 2008;7:771-782. https://doi.org/10.1038/nrd2614
  6. Berry G, Billingham M, Alderman E, et al. The use of cardiac biopsy to demonstrate reduced cardiotoxicity in AIDS Kaposi’s sarcoma patients treated with pegylated liposomal doxorubicin. Ann Oncol. 1998;9:711-716. PMID: 9739435.
  7. Gref R, Minamitake Y, Peracchia MT, et al. Biodegradable long-circulating polymeric nanospheres. Science. 1994;263:1600-1603. PMID:8128245.
  8. Zamboni WC, Torchilin V, Patri AK, et al. Best practices in cancer nanotechnology: perspective from NCl nanotechnology alliance. Clin Cancer Res. 2012;18:3229-3241. https://doi.org/10.1158/1078-0432.CCR-11-2938
  9. Wang AZ, Langer R, Farokhzad OC. Nanoparticle delivery of cancer drugs. Annu Rev Med. 2012;63:185-198. https://doi.org/10.1146/annurev-med-040210-162544
  10. Mishra B, Patel BB, Tiwari S. Colloidal nanocarriers: a review on formulation technology, types and applications toward targeted drug delivery. Nanomedicine. 2010;6:9-24. https://doi.org/10.1016/j.nano.2009.04.008
  11. Freitas RAJr. Nanomedicine, Volume 1: Basic Capabilities. Georgetown, TX: Landes Bioscience; 1999.
  12. Marradi M, Martin-Lomas M, Penades S. Glyconanoparticles polyvalent tools to study carbohydrate-based interactions. Adv Carbohydr Chem Biochem. 2010;64:211-290. https://doi.org/10.1016/S0065-2318(10)64005-X
  13. Morris SA, Farrell D, Grodzinski P. Nanotechnologies in cancer treatment and diagnosis. J Natl Compr Canc Netw. 2014;12:1727-1733. PMID: 25505214.
  14. Chow EK, Ho D. Cancer nanomedicine: from drug delivery to imaging. Sci Transl Med. 2013;5:216rv4. https://doi.org/10.1126/scitranslmed.3005872
  15. Jensen SA, Day ES, Ko CH, et al. Spherical nucleic acid nanoparticle conjugates as an RNAi-based therapy for glioblastoma. Sci Transl Med. 2013;5:209ra152. https://doi.org/10.1126/scitranslmed.3006839
  16. Jiang W, Kim BY, Rutka JT, et al. Nanoparticle-mediated cellular response is size-dependent. Nat Nanotechnol. 2008;3:145-150. https://doi.org/10.1038/nnano.2008.30
  17. Zhao F, Zhao Y, Liu Y, et al. Cellular uptake, intracellular trafficking, and cytotoxicity of nanomaterials. Small. 2011;7:1322-1337. https://doi.org/10.1002/smll.201100001
  18. Gratton SE, Ropp PA, Pohlhaus PD, et al. The effect of particle design on cellular internalization pathways. Proc Natl Acad Sci USA. 2008;105:11613-11618. https://doi.org/10.1073/pnas.0801763105
  19. Venturoli D, Rippe B. Ficoll and dextran vs. globular proteins as probes for testing glomerular permselectivity: effects of molecular size, shape, charge, and deformability. Am J Physiol Renal Physiol. 2005;288:605-613. https://doi.org/10.1152/ajprenal.00171.2004
  20. Moghimi SM, Hunter AC, Murray JC. Long-circulating and target-specific nanoparticles: theory to practice. Pharmacol Rev. 2001;53:283-318. PMID:11356986.
  21. Owens DE 3rd, Peppas NA. Opsonization, biodistribution, and pharmacokinetics of polymeric nanoparticles. Int J Pharm. 2006;307:93-102. https://doi.org/10.1016/j.ijpharm.2005.10.010
  22. Lemarchand C, Gref R, Couvreur P. Polysaccharide-decorated nanoparticles. Eur J Pharm Biopharm. 2004;58:327-341. https://doi.org/10.1016/j.ejpb.2004.02.016
  23. Carstensen H, Muller RH, Muller BW. Particle-size, surface hydrophobicity and interaction with serum of parenteral fat emulsions and model-drug carriers as parameters related to RES uptake. Clin Nutr. 1992;11:289-297. PMID: 16840011.
  24. Norman ME, Williams P, Illum L. Human serum-albumin as a probe for surface conditioning (opsonization) of block copolymer-coated microspheres. Biomaterials. 1992;13:841-849. PMID: 1457677.
  25. Roser M, Fischer D, Kissel T. Surface-modified biodegradable albumin nano- and microspheres. II: effect of surface charges on in vitro phagocytosis and biodistribution in rats. Eur J Pharm Biopharm. 1998;46:255-263. PMID:9885296.
  26. Fang J, Nakamura H, Maeda H. The EPR effect: unique features of tumor blood vessels for drug delivery, factors involved, and limitations and augmentation of the effect. Adv Drug Deliv Rev. 2011;63:136-151. https://doi.org/10.1016/j.addr.2010.04.009
  27. Peer D, Karp JM, Hong S, et al. Nanocarriers as an emerging platform for cancer therapy. Nat Nanotechnol. 2007;2:751-760. https://doi.org/10.1038/nnano.2007.387
  28. Heath JR, Davis ME. Nanotechnology and cancer. Annu Rev Med. 2008;59:251-265. https://doi.org/10.1146/annurev.med.59.061506.185523
  29. Barratt G. Colloidal drug carriers: achievements and perspectives. Cell Mol Life Sci. 2003;60:21-37. PMID:12613656.
  30. Cheng Z, Al Zaki A, Hui JZ, et al. Multifunctional nanoparticles: cost versus benefit of adding targeting and imaging capabilities. Science. 2012;338:903-910. https://doi.org/10.1126/science.1226338
  31. Kano MR, Bae Y, Iwata C, et al. Improvement of cancer-targeting therapy, using nanocarriers for intractable solid tumors by inhibition of TGF-beta signaling. Proc Natl Acad Sci USA. 2007;104:3460-3465. https://doi.org/10.1073/pnas.0611660104
  32. Schnyder A, Krahenbuhl S, Drewe J, et al. Targeting of daunomycin using biotinylated immunoliposomes: pharmacokinetics, tissue distribution and in vitro pharmacological effects. J Drug Target. 2005;13:325-335. https://doi.org/10.1080/10611860500206674
  33. Clark AJ, Davis ME. Increased brain uptake of targeted nanoparticles by adding an acid-cleavable linkage between transferrin and the nanoparticle core. Proc Natl Acad Sci USA. 2015;112:12486-12491. https://doi.org/10.1073/pnas.1517048112/-/DCSupplemental
  34. Antony AC, Kane MA, Portillo RM, et al. Studies of the role of a particulate folate-binding protein in the uptake of 5-methyltetrahydrofolate by cultured human KB cells. J Biol Chem. 1985;260:14911-14917. PMID:4066659.
  35. Pan XQ, Wang H, Lee RJ. Antitumor activity of folate receptor-targeted liposomal doxorubicin in a KB oral carcinoma murine xenograft model. Pharm Res. 2003;20:417-422. PMID:12669962.
  36. Kukowska-Latallo JF, Candido KA, Cao Z, et al. Nanoparticle targeting of anticancer drug improves therapeutic response in animal model of human epithelial cancer. Cancer Res. 2005;65:5317-5324. https://doi.org/10.1158/0008-5472.CAN-04-3921
  37. Lee ES, Na K, Bae YH. Polymeric micelle for tumor pH and folate-mediated targeting. J Control Release. 2003;91:103-113. PMID:12932642.
  38. Yang X, Grailer JJ, Rowland IJ, et al. Multifunctional stable and pH-responsive polymer vesicles formed by heterofunctional triblock copolymer for targeted anticancer drug delivery and ultrasensitive MR imaging. ACS Nano. 2010;4:6805-6817. https://doi.org/10.1021/nn101670k
  39. Ling D, Xia H, Park W, et al. pH-sensitive nanoformulated triptolide as a targeted therapeutic strategy for hepatocellular carcinoma. ACS Nano. 2014;8:8027-8039. https://doi.org/10.1021/nn502074x
  40. Edgington TS, Mackman N, Brand K, et al. The structural biology of expression and function of tissue factor. Thromb Haemostasis. 1991;66:67-79. PMID:1833852.
  41. Shi W, Mei H, Deng J, et al. A tissue factor targeted nanomedical system for thrombi-specific drug delivery. Biomaterials. 2012;33:7643-7654. https://doi.org/10.1016/j.biomaterials.2012.06.094
  42. Kang KN, Lee YS. RNA aptamers: a review of recent trends and applications. In: Zhong J., editor. Future Trends in Biotechnology, Vol. 131. Heidelberg: Springer; 2013. https://doi.org/10.1007/10_2012_136
  43. Farokhzad OC, Cheng J, Teply BA, et al. Targeted nanoparticle-aptamer bioconjugates for cancer chemotherapy in vivo. Proc Natl Acad Sci USA. 2006;103:6315-6320. https://doi.org/10.1073/pnas.0601755103
  44. Smith GP, Petrenko VA. Phage display. Chem Rev. 1997;97:391-410. PMID: 11848876.
  45. Simberg D, Duza T, Park JH, et al. Biomimetic amplification of nanoparticle homing to tumors. Proc Natl Acad Sci USA. 2007;104:932-936. https://doi.org/10.1073/pnas.0610298104
  46. Agemy L, Sugahara KN, Kotamraju VR, et al. Nanoparticle-induced vascular blockade in human prostate cancer. Blood. 2010;116:2847-2856. https://doi.org/10.1182/blood-2010-03-274258
  47. Chung EJ, Cheng Y, Morshed R, et al. Fibrin-binding, peptide amphiphile micelles for targeting glioblastoma. Biomaterials. 2014;35:1249-1256. https://doi.org/10.1016/j.biomaterials.2013.10.064
  48. Peters D, Kastantin M, Kotamraju VR, et al. Targeting atherosclerosis by using modular, multifunctional micelles. Proc Natl Acad Sci USA. 2009;106:9815-9819. https://doi.org/10.1073/pnas.0903369106
  49. Bertram JP, Williams CA, Robinson R, et al. Intravenous hemostat: nano-technology to halt bleeding. Sci Transl Med. 2009;1:11ra22. https://doi.org/10.1126/scitranslmed.3000397
  50. Gu F, Zhang L, Teply BA, et al. Precise engineering of targeted nanoparticles by using self-assembled biointegrated block copolymers. Proc Natl Acad Sci USA. 2008;105:2586-2591. https://doi.org/10.1073/pnas.0711714105
  51. Fakhari A, Baoum A, Siahaan TJ, et al. Controlling ligand surface density optimizes nanoparticle binding to ICAM-1. J Pharm Sci. 2011;100:1045-1056. https://doi.org/10.1002/jps.22342
  52. Duncan GA, Bevan MA. Computational design of nanoparticle drug delivery systems for selective targeting. Nanoscale. 2015;7:15332-15340. https://doi.org/10.1039/c5nr03691g
  53. Moyer TJ, Kassam HA, Bahnson ESM, et al. Shape-dependent targeting of injured blood vessels by peptide amphiphile supramolecular nanostructures. Small. 2015;11:2750-2755. https://doi.org/10.1002/smll.201403429
  54. Agarwal A, Mackey MA, El-Sayed MA, et al. Remote triggered release of doxorubicin in tumors by synergistic application of thermosensitive liposomes and gold nanorods. ACS Nano. 2011;5:4919-4926. https://doi.org/10.1021/nn201010q
  55. Kurtoglu YE, Navath RS, Wang B, et al. Poly(amidoamine) dendrimer-drug conjugates with disulfide linkages for intracellular drug delivery. Biomaterials. 2009;30:2112-2121. https://doi.org/10.1016/j.biomaterials.2008.12.054
  56. Engin K, Leeper DB, Cater JR, et al. Extracellular pH distribution in human tumours. Int J Hyperther. 1995;11:211-216. https://doi.org/10.3109/02656739509022457
  57. Seo JW, Baek H, Mahakian LM, et al. (64)Cu-labeled LyP-1-dendrimer for PET-CT imaging of atherosclerotic plaque. Bioconjug Chem. 2014;25:231-239. https://doi.org/10.1021/bc400347s
  58. Li C, Cao L, Zhang Y, et al. Preoperative detection and intraoperative visualization of brain tumors for more precise surgery: a new dual-modality MRI and NIR nanoprobe. Small. 2015;11:4517-4525. https://doi.org/10.1002/smll.201500997
  59. Bagalkot V, Badgeley MA, Kampfrath T, et al. Hybrid nanoparticles improve targeting to inflammatory macrophages through phagocytic signals. J Control Release. 2015;217:243-255.
  60. Joy T, Hegele RA. Is raising HDL a futile strategy for atheroprotection? Nat Rev Drug Discov. 2008;7:143-155. https://doi.org/10.1016/j.jconrel.2015.09.027
  61. Thaxton CS, Daniel WL, Giljohann DA, et al. Templated spherical high density lipoprotein nanoparticles. J Am Chem Soc. 2009;131:1384-1385. https://doi.org/10.1021/ja808856z
  62. Luthi AJ, Zhang H, Kim D, et al. Tailoring of biomimetic high-density lipoprotein nanostructures changes cholesterol binding and efflux. ACS Nano. 2012;6:276-285. https://doi.org/10.1021/nn2035457
  63. Yu M, Jie X, Xu L, et al. Recent advances in dendrimer research for cardiovascular diseases. Biomacromolecules. 2015;16:2588-2598. https://doi.org/10.1021/acs.biomac.5b00979
  64. Chan LW, Wang X, Wei H, et al. A synthetic fibrin cross-linking polymer for modulating clot properties and inducing hemostasis. Sci Transl Med. 2015;7:277ra29. https://doi.org/10.1126/scitranslmed.3010383
  65. Morgan CE, Wasserman MA, Kibbe MR. Targeted nanotherapies for the treatment of surgical diseases. Annals of surgery. 2016;263:5:900-907. https://doi.org/10.1097/SLA.0000000000001605
  66. Drozdov AS, Vinogradov VV, Dudanov IP. Leach-prof magnetic thrombolytic nanoparticles and coatings of enhanced activity. Scientific reports. 2016;6:28119. https://doi.org/10.1038/srep28119
  67. Bernelot Moens SJ, van Capelleveen JC, Stroes ES. Inhibition of ApoCIII: the next PCSK9? Curr Opin Lipidol. 2014;25:418-422. https://doi.org/10.1097/MOL.0000000000000130
  68. van der Valk FM, Kroon J, Potters WV, Thurlings RM, Bennink RJ, Verberne HJ, Nederveen AJ, Nieuwdorp M, Mulder WJ, Fayad ZA, van Buul JD, Stroes ES. In vivo imaging of enhanced leukocyte accumulation in atherosclerotic lesions in humans. J Am Coll Cardiol. 2014;64:1019-1029. https://doi.org/10.1016/j.jacc.2014.06.1171
Contact the author
Email
Message
The publishing house "Media Sphere" does not provide treatment services, does not give recommendations on contacting medical institutions and specific specialists, on the prescription of medicines and dietary supplements.

Email Confirmation

An email was sent to test@gmail.com with a confirmation link. Follow the link from the letter to complete the registration on the site.

Email Confirmation

Submit Application

You can become an author of one of our magazines, send a request and we will consider it in during the day.

Name
Phone
E-mail
Message
Login
Registration
E-mail
Password
Forgot Password?

Log in to the site using your account in one of the services

Password recovery
E-mail
Login
Register

We use cооkies to improve the performance of the site. By staying on our site, you agree to the terms of use of cооkies. To view our Privacy and Cookie Policy, please. click here.